SCHEMBL9706281

SCHEMBL9706281

Cc1cc(CCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
SCARB1 Q8WTV0 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE10A Q9Y233 2/20 0.32
HDAC6 Q9UBN7 1/20 0.32
ALDH1A1 P00352 2/20 0.31
LTA4H P09960 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP19A1 P11511 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
IGF1R P08069 1/20 0.30
FGFR1 P11362 1/20 0.30
KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9705761 0.96 NR1I2 (0.39) NR1I2CYP3A4CYP2D6SCARB1KCNH2
Win-54954 SCHEMBL8755546 0.96 NR1I2 (0.39) NR1I2CYP3A4CYP2D6SCARB1KCNH2
SCHEMBL9705776 0.96 NR1I2 (0.39) NR1I2CYP3A4CYP2D6SCARB1KCNH2
SCHEMBL9705828 0.91 NR1I2 (0.44) NR1I2CYP3A4CYP2D6SCARB1KCNH2
SCHEMBL9705686 0.90 ALDH1A1 (0.38) NR1I2CYP3A4CYP2D6SCARB1KCNH2
SCHEMBL9862971 0.87 CYP3A4 (0.38) NR1I2CYP3A4CYP2D6SCARB1
SCHEMBL9705747 0.86 NR1I2 (0.43) NR1I2CYP3A4CYP2D6
SCHEMBL9705719 0.86 NR1I2 (0.40) NR1I2CYP3A4CYP2D6SCARB1KCNH2
SCHEMBL9705792 0.85 PDE10A (0.33) NR1I2CYP3A4CYP2D6PDE10AHDAC6
SCHEMBL9705985 0.85 NR1I2 (0.34) NR1I2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed
US-7371755-B1 Antiviral agents BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2008-05-13 US disclosed
EP-0207454-B1 ISOXAZOLE AND FURAN DERIVATIVES, THEIR PREPARATION AND USE AS ANTIVIRAL AGENTS STERLING WINTHROP INC. (US) 1992-09-09 EP disclosed
US-5002960-A Viricides for combating picornaviruses STERLING DRUG, INC. (US) 1991-03-26 US disclosed
US-4939267-A Viricides STERLING DRUG INC. (US) 1990-07-03 US disclosed
US-4843087-A OXAZOLINYL COMPOUNDS; RHINOVIRUSES AND PICORNAVIRUSES STERLING DRUG INC. (US) 1989-06-27 US disclosed
EP-0207454-A2 Isoxazole and furan derivatives, their preparation and use as antiviral agents STERLING WINTHROP INC. (US) 1987-01-07 EP disclosed